文献速递肺外科

同期原发性非小细胞肺癌根治性切除后结局:双原发劣于单发

Outcomes After Curative-intent Resection of Synchronous Primary Non-small cell lung cancer (NSCLC): Two is Worse than One.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-10-28

本研究回顾性分析2006-2020年退伍军人健康管理局中接受根治性切除的临床I期NSCLC患者,比较同期原发性肺癌(SPLC)与单发肿瘤的复发和生存。倾向评分匹配后,SPLC与更高的累积复发率(HR 1.51,95%CI 1.10-2.07)、更差的无病生存(HR 1.24,95%CI 1.03-1.50)和总生存(HR 1.21,95%CI 1.01-1.45)相关。双肿瘤楔形切除与SPLC复发独立相关。

要点

  • SPLC占临床I期NSCLC根治性切除患者的2.7%。
  • 匹配后SPLC复发风险增加51%,生存更差。
  • 双楔形切除是SPLC复发的独立危险因素。

核心结论

  • 校正后SPLC与单发肿瘤相比复发更高、生存更差,应视为临床I期NSCLC中的高危表型。

研究设计与样本

  • 回顾性队列研究,纳入退伍军人健康管理局2006-2020年接受根治性切除的临床I期NSCLC患者,共12606例,其中SPLC 337例(2.7%)。
  • SPLC定义为六周内诊断的两个 distinct 临床I期NSCLC肿瘤,且一年内对两个肿瘤均行根治性治疗。
  • 采用1:1倾向评分匹配比较SPLC与单发肿瘤,匹配队列281对。

主要发现

  • SPLC患者肿瘤更大、病理分期更晚,44.2%的SPLC病例两肿瘤组织学不一致。
  • 匹配队列中SPLC的累积复发率更高(HR 1.51,95%CI 1.10-2.07),无病生存更差(HR 1.24,95%CI 1.03-1.50),总生存更差(HR 1.21,95%CI 1.01-1.45)。
  • 在SPLC患者中,双肿瘤均行楔形切除与复发独立相关。

临床怎么用

  • 临床I期NSCLC若为SPLC,应认识到其复发和死亡风险高于单发肿瘤,需更密切随访。
  • 对SPLC行双楔形切除可能增加复发风险,选择术式时应考虑更根治性切除。

局限性

  • 回顾性研究,仅纳入退伍军人群体,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Outcomes following curative-intent resection of synchronous primary lung cancer (SPLC) remain incompletely defined. We compared recurrence and survival in SPLC versus solitary primary tumors among patients with clinical stage I non-small cell lung cancer (NSCLC). METHODS: Retrospective cohort study of Veterans undergoing curative-intent resection for clinical stage I NSCLC in the Veterans Health Administration (2006-2020). SPLC was defined as two distinct clinical stage I NSCLC tumors diagnosed within six weeks, with curative-intent treatment of both tumors within one year. Propensity score matching (PSM) (1:1) was used to compare patients with SPLC to those with solitary tumors. The primary outcome was cumulative incidence of recurrence (CIR); secondary outcomes were overall survival (OS) and disease-free survival (DFS). Additional analyses examined the role of adjuvant treatment and drivers of recurrence in SPLC patients. RESULTS: Of 12,606 Veterans with resected clinical stage I NSCLC, 337 (2.7%) had SPLC. SPLC presented with larger tumors and more advanced pathologic stage. Histology was discordant between the two tumors in 44.2% of SPLC cases. In the propensity-matched cohort (281 pairs), SPLC was associated with higher CIR (HR 1.51, 95% CI 1.10-2.07), worse DFS (HR 1.24, 95% CI 1.03-1.50), and worse OS (HR 1.21, 95% CI 1.01-1.45). Within SPLC, wedge resection of both tumors was independently associated with recurrence. CONCLUSIONS: After adjustment, SPLC was associated with higher recurrence and worse survival than solitary tumors, supporting recognition of SPLC as a higher-risk phenotype within clinical stage I NSCLC.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Seyoum N, Eaton DB, Brennan L, et al. Outcomes After Curative-intent Resection of Synchronous Primary Non-small cell lung cancer (NSCLC): Two is Worse than One. J Thorac Cardiovasc Surg. 2026. PMID: 42951128. doi:10.1016/j.jtcvs.2026.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。